Clinical Trials and Patient Safety
Get it right, make it safe. See how AI-augmented RBQM and Quality by Design work together to cut avoidable burden and safeguard patients, from Protocol Complexity Analysis at design to AI-enhanced Subject Profiles in medical monitoring.
FDA Finalizes ICH E6(R3) Guidance, But U.S. Timeline Still Unclear
The FDA has published the finalized ICH E6(R3) Good Clinical Practice guidance. Unlike Europe’s July 23 deadline, the U.S. implementation date is still to be announced. This creates uncertainty for sponsors and CROs operating across regions, highlighting the importance of early preparation and alignment with global standards.
Law of Attraction & Power of Imagination
In our community learning session with Giray Görbil (Clinical Marketing Coordinator at Cyntegrity), we explored the fascinating connection between the "Law of Attraction and the Power of Imagination". These two concepts, when combined, can [...]
Selling Across Cultures: Pitching to Global Clients
In today’s global market, success isn’t just about offering a great product or service it’s about connecting with people from different cultures in a meaningful way. The latest Community Learning Session with Julien Goncalves [...]